China Biotech Services Holdings Limited reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was HKD 302.82 million compared to HKD 219.99 million a year ago. Net income was HKD 33.28 million compared to HKD 22.42 million a year ago. Basic earnings per share from continuing operations was HKD 0.035 compared to HKD 0.023 a year ago.
For the six months, sales was HKD 686.91 million compared to HKD 374.16 million a year ago. Net income was HKD 68.22 million compared to HKD 24.24 million a year ago. Basic earnings per share from continuing operations was HKD 0.071 compared to HKD 0.025 a year ago.